63 related articles for article (PubMed ID: 25293325)
1. Fluorescence-based, high-throughput assays for μ-opioid receptor activation using a membrane potential-sensitive dye.
Knapman A; Connor M
Methods Mol Biol; 2015; 1230():177-85. PubMed ID: 25293325
[TBL] [Abstract][Full Text] [Related]
2. A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells.
Knapman A; Abogadie F; McIntrye P; Connor M
J Biomol Screen; 2014 Feb; 19(2):223-31. PubMed ID: 23989451
[TBL] [Abstract][Full Text] [Related]
3. A continuous, fluorescence-based assay of μ-opioid receptor activation in AtT-20 cells.
Knapman A; Santiago M; Du YP; Bennallack PR; Christie MJ; Connor M
J Biomol Screen; 2013 Mar; 18(3):269-76. PubMed ID: 23015017
[TBL] [Abstract][Full Text] [Related]
4. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2015 May; 172(9):2258-72. PubMed ID: 25521224
[TBL] [Abstract][Full Text] [Related]
5. Rapid assessment of G protein signaling of four opioid receptors using a real-time fluorescence-based membrane potential assay.
Dasgupta P; Günther T; Reinscheid RK; Zaveri NT; Schulz S
Eur J Pharmacol; 2021 Jan; 890():173640. PubMed ID: 33045198
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.
Knapman A; Santiago M; Connor M
Br J Pharmacol; 2014 Sep; 171(18):4273-88. PubMed ID: 24846673
[TBL] [Abstract][Full Text] [Related]
7. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
8. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
9. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
Shy M; Chakrabarti S; Gintzler AR
Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
[TBL] [Abstract][Full Text] [Related]
10. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
11. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
[TBL] [Abstract][Full Text] [Related]
12. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
Szücs M; Boda K; Gintzler AR
J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
[TBL] [Abstract][Full Text] [Related]
13. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.
Wang H; Guang W; Barbier E; Shapiro P; Wang JB
Neuroreport; 2007 Dec; 18(18):1969-73. PubMed ID: 18007196
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced functional desensitization of the mu-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein.
Pak Y; Kouvelas A; Scheideler MA; Rasmussen J; O'Dowd BF; George SR
Mol Pharmacol; 1996 Nov; 50(5):1214-22. PubMed ID: 8913353
[TBL] [Abstract][Full Text] [Related]
15. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
16. delta-Opioid receptors are more efficiently coupled to adenylyl cyclase than to L-type Ca(2+) channels in transfected rat pituitary cells.
Prather PL; Song L; Piros ET; Law PY; Hales TG
J Pharmacol Exp Ther; 2000 Nov; 295(2):552-62. PubMed ID: 11046088
[TBL] [Abstract][Full Text] [Related]
17. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
Tso PH; Wong YH
J Pharmacol Exp Ther; 2000 Oct; 295(1):168-76. PubMed ID: 10991975
[TBL] [Abstract][Full Text] [Related]
18. Chronic opioid treatment augments caveolin-1 scaffolding: relevance to stimulatory μ-opioid receptor adenylyl cyclase signaling.
Chakrabarti S; Chang A; Liu NJ; Gintzler AR
J Neurochem; 2016 Dec; 139(5):737-747. PubMed ID: 27726130
[TBL] [Abstract][Full Text] [Related]
19. Effect of electromagnetic field on cyclic adenosine monophosphate (cAMP) in a human mu-opioid receptor cell model.
Ross CL; Teli T; Harrison BS
Electromagn Biol Med; 2016; 35(3):206-13. PubMed ID: 26151161
[TBL] [Abstract][Full Text] [Related]
20. Assessing opioid regulation of adenylyl cyclase activity in intact cells.
Thakker DR; Ozsoy HZ; Standifer KM
Methods Mol Med; 2003; 84():29-37. PubMed ID: 12703314
[No Abstract] [Full Text] [Related]
[Next] [New Search]
